Frequency Therapeutics

BioSpace Layoff Tracker 2023: Grifols, Frequency, Eliem and More Cut Staff
BioSpace Layoff Tracker 2023: Grifols, Frequency, Eliem and More Cut Staff
BioSpace
layoffs
Grifols
Frequency Therapeutics
Eliem Therapeutics
Aligos Therapeutics
Thermo Fisher Scientific
Magenta Therapeutics
Eisai
Amgen
Y-mAbs Therapeutics
Century Therapeutics
Elevation Oncology
Calithera Biosciences
Editas Medicine
Verily
Abzena
Flag link:
Frequency Therapeutics reports trial fail and lays off over half of staff — stock capsizes
Frequency Therapeutics reports trial fail and lays off over half of staff — stock capsizes
Endpoints
Frequency Therapeutics
layoffs
clinical trials
hearing loss
Flag link:
Frequency doses first patient in Phase Ib sensorineural hearing loss trial
Frequency doses first patient in Phase Ib sensorineural hearing loss trial
Clinical Trials Arena
Frequency Therapeutics
FX-345
clinical trials
sensorineural hearing loss
Flag link:
Three Biotechs Raise $320M in IPOs, Two Others Pass on Wall Street
Three Biotechs Raise $320M in IPOs, Two Others Pass on Wall Street
Xconomy
IPOs
Viela Bio
Frequency Therapeutics
Aprea Therapeutics
ADC Therapeutics
Monopar Therapeutics
Flag link:
Led by BioNTech, six biotechs line up for October IPOs
Led by BioNTech, six biotechs line up for October IPOs
Endpoints
IPOs
MRNA
melanoma
inebilizumab
NMOSD
blood cancer
solid tumors
BioNTech
ADC Therapeutics
Viela Bio
Frequency Therapeutics
Aprea Therapeutics
Monopar Therapeutics
Flag link:
Frequency Therapeutics Updates $123 Million IPO Filing
Frequency Therapeutics Updates $123 Million IPO Filing
CP Wire
Frequency Therapeutics
IPOs
Flag link:
Frequency Therapeutics Updates $123 Million IPO Filing
Frequency Therapeutics
Flag link:
Frequency bags $62M to advance Astellas-partnered hearing loss drug
Frequency bags $62M to advance Astellas-partnered hearing loss drug
Fierce Biotech
Frequency Therapeutics
hearing loss
Astellas
FX-322
Flag link:
On heels of trial readout, Frequency out-licenses hearing loss therapy to Astellas
On heels of trial readout, Frequency out-licenses hearing loss therapy to Astellas
BioCentury
Frequency Therapeutics
hearing loss
FX-322
Astellas
Flag link:
Frequency Nabs $42M for Hearing Loss Drugs, Clinical Data On The Way
Frequency Nabs $42M for Hearing Loss Drugs, Clinical Data On The Way
Xconomy
Frequency Therapeutics
hearing loss
Flag link:
The 10 hottest medtech startups of 2017
The 10 hottest medtech startups of 2017
Mass Device
devices
startups
Basil Leaf Technologies
BioLert
Catalia Health
Frequency Therapeutics
Green Sun Medical
Ivenix
Madorra
NeuSpera Medical
Onkos Surgical
Renova Care
Flag link:
Hearing loss biotech Frequency Therapeutics dials up $32M round
Hearing loss biotech Frequency Therapeutics dials up $32M round
Bizjournals.com
hearing loss
Frequency Therapeutics
Flag link: